News

Ambulatory BP Tops In-Office Measures in Predicting CVD


 

SAN FRANCISCO — Ambulatory blood pressure monitoring in the general population was a better predictor of cardiovascular mortality and morbidity than in-office blood pressure measurements in a 10-year study, Tine Willum Hansen, M.D., reported.

The investigators recorded baseline ambulatory and in-office blood pressure readings and other risk factors in 1,700 people aged 41–72 years who had no major cardiovascular diseases. The subjects were followed up 9.5 years later; 156 subjects had died of cardiovascular disease, had a stroke, or developed ischemic heart disease during that decade, she said at the annual meeting of the American Society of Hypertension.

For ambulatory measurements, every 10-mm Hg increase in systolic blood pressure at baseline, the relative risk for these three end points combined (cardiovascular death, ischemic heart disease, and stroke) increased by 35%. For every 10-mm Hg increase in diastolic blood pressure at baseline, the relative risk increased 27%, said Dr. Hansen of the Research Center for Prevention and Health, Copenhagen.

In contrast, for in-office measurements at baseline, every 10-mm Hg increase in systolic blood pressure raised the risk of the combined end points by 18%, and each 10-mm Hg increase in diastolic pressure raised the risk by 11%.

Only ambulatory blood pressure was a significant predictor of risk for the combined end points, Dr. Hansen said.

Compared with normotensive subjects at baseline, those with sustained hypertension based on either ambulatory or in-office measurements were more than twice as likely to die of cardiovascular disease or develop ischemic heart disease or stroke. Of normotensive subjects, 6% developed one of these end points, compared with 17% of those with sustained hypertension—a significant difference.

Compared with normotensives, subjects with isolated ambulatory hypertension showed a trend toward increased risk for the combined end points; this trend did not reach statistical significance. A similar trend was not seen in subjects with isolated in-office hypertension.

Among 474 “nondippers” (people whose blood pressures fell less than 10% at night) based on ambulatory measurements, those with hypertension had a 68% higher risk for the combined end points than did normotensive subjects, Dr. Hansen said.

Recommended Reading

Simvastatin, Pravastatin May Lower Blood Pressure
MDedge Cardiology
Inhaled Iloprost Approved for Pulmonary Arterial Hypertension
MDedge Cardiology
ASCOT at Odds With JNC Recommendations
MDedge Cardiology
ACE Inhibitor-Related Angioedema Risk Higher in African Americans
MDedge Cardiology
Nicardipine Seen Safe for Use In Hypertensive Emergencies
MDedge Cardiology
Simple Regimen Reins In Resistant Hypertension : Adding angiotensin II receptor blocker to diuretic brought hard-to-treat hypertensives below target BP.
MDedge Cardiology
In-Office Detection of White Coat Hypertension Is Possible
MDedge Cardiology
Combination Lipid/BP Treatment Reduces Events : Lower event rates with calcium channel blocker and statin are attributed to improved arterial elasticity.
MDedge Cardiology
Novel Drug Found Safe, Effective in Pulmonary Arterial Hypertension
MDedge Cardiology
Adherence Better With Home BP Monitoring
MDedge Cardiology